Phospholipase Cγ1 stimulates transcriptional activation of the matrix metalloproteinase-3 gene via the protein kinase C/Raf/ERK cascade

Biochemical and Biophysical Research Communications

Volumn 353, Issue 3, 2007, Pages 611-616

  Shin, Soon Young ^a   Choi, Ha Young ^b   Ahn, Bong Hyun ^c   Min, Do Sik ^d   Son, Sang Wook ^e   Lee, Young Han ^b  

^a Hanyang University   (South Korea)

^b Department of Bio Nano Technology   (South Korea)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d Pusan National University   (South Korea)

^e Korea University College of Medicine   (South Korea)

Author keywords

MAPK; MMP 3; PLC 1; Protein kinase C

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE C GAMMA1; PROTEIN KINASE C; RAF PROTEIN; STROMELYSIN; PHOSPHOLIPASE C GAMMA;

ANIMAL CELL; ARTICLE; CANCER INVASION; CELL MATURATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; GENE OVEREXPRESSION; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TUMOR GROWTH; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL MOTION; CELL STRAIN 3T3; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; PROMOTER REGION; WOUND HEALING;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MATRIX METALLOPROTEINASE 3; MICE; NIH 3T3 CELLS; PHOSPHOLIPASE C GAMMA; PROMOTER REGIONS (GENETICS); PROTEIN KINASE C; RAF KINASES; RATS; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 33846000588     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.12.064     Document Type: Article

References (28)

1. Stamenkovic I. Extracellular matrix remodelling: the role of matrix metallopreteases. J. Pathol. 200 (2003) 448-464
2. John A., and Tuszynski G. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol. Oncol. Res. 7 (2001) 14-23
3. Johnson J.L., George S.J., Newby A.C., and Jackson C.L. Divergent effects of matrix metalloproteinases 3,7,9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries. Proc. Natl. Acad. Sci. USA 102 (2005) 15575-15580
4. Deryugina E.I., and Quigley J.P. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 25 (2006) 9-34
5. Sternlicht M.D., Bissell M.J., and Werb Z. The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter. Oncogene 19 (2000) 1102-1113
6. Themsche C.V., Potworowski E.F., and St-Pierre Y. Stromelysin-1 (MMP-3) is inducible in T lymphoma cells and accelerates the growth of lymphoid tumors in vivo. Biochem. Biophys. Res. Commun. 315 (2004) 884-891
7. Kim M.J., Kim E., Ryu S.H., and Suh P.G. The mechanism of phospholipase Cγ1 regulation. Exp. Mol. Med. 32 (2000) 101-109
8. Soderquist A.M., Todderud G., and Carpenter G. Elevated membrane association of phospholipase Cγ1 in MDA-468 mammary tumor cells. Cancer Res. 52 (1992) 4526-4529
9. Park J.-G., Lee Y.H., Kim S.S., Park K.J., Hoh D.-Y., Pyu S.H., and Suh P.-G. Overexpression of phospholipase Cγ1 in familial adenomatous polyposis. Cancer Res. 54 (1994) 2240-2244
10. Chang J.S., Noh D.Y., Park I.A., Kim M.J., Song H., Ryu S.H., and Suh P.-G. Overexpression of phospholipase Cγ1 in rat 3Y1 fibroblast cells leads to malignant transformation. Cancer Res. 57 (1997) 5465-5468
11. Smith M.R., Court D.W., Kim H.-K., Park J.B., Rhee S.G., Rhim J.S., and Kung H.F. Overexpression of phosphoinositide-specific phospholipase Cγ in NIH 3T3 cells promotes transformation and tumorigenicity. Carcinogenesis 19 (1998) 177-185
12. Chen P., Xie H., Sekar M.C., Gupta K., and Wells A. Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. J. Cell. Biol. 127 (1994) 847-857
13. Turner T., Chen P., Goodly L.J., and Wells A. EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells. Clin. Exp. Metastasis 14 (1996) 409-418
14. Khoshyomn S., Penar P.L., Rossi J., Wells A., Abramson D.L., and Bhushan A. Inhibition of phospholipase Cγ1 activation blocks glioma cell motility and invasion of fetal rat brain aggregates. Neurosurgery 44 (1999) 568-578
15. Dittmar T., Husemann A., Schewe Y., Nofer J.-R., Niggemann B., Zanker K.S., and Brandt B.H. Induction of cancer cell migration by epidermal growth factor is initiated by specific phosphorylation of tyrosine 1248 of c-erbB-2 receptor via epidermal growth factor receptor. FASEB J. 16 (2002) 1823-1825
16. Chang J.S., Noh D.Y., Park I.A., Kim M.J., Song H., Ryu S.H., and Suh P.G. Overexpression of phospholipase Cγ1 in rat 3Y1 fibroblast cells leads to malignant transformation. Cancer Res. 57 (1997) 5465-5468
17. Min D.S., Kwon T.K., Park W.-S., Chang J.-S., Park S.-K., Ahn B.-H., Ryoo Z.-Y., Lee Y.H., Lee Y.S., Rhie D.-J., Yoon S.-H., Hahn S.J., Kim M.-S., and Jo Y.-H. Neoplastic transformation and tumorigenesis associated with overexpression of phospholipase D isozymes in cultured murine fibroblasts. Carcinigenesis 22 (2001) 1641-1647
18. Shin S.Y., Kim C.G., Ko J., Min D.S., Chang J.-S., Ohba M., Kuroki T., Choi Y.B., Kim Y.-H., and Na D.S. Transcriptional and post-transcriptional regulation of the PKCδ gene by etoposide in L1210 murine leukemia cells: Implication of PKCδ autoregulation. J. Mol. Biol. 340 (2004) 681-693
19. Shin S.Y., Ko J., Chang J.-S., Min D.S., Choi C., Bae S.S., Kim M.J., Hyun D.S., Kim J.-H., Han M.Y., Kim Y.-H., Kim Y.S., Na D.S., Suh P.-G., and Lee Y.H. Negative regulatory role of overexpression of PLCγ1 in the expression of early growth response 1 gene in rat 3Y1 fibroblasts. FASEB J. 16 (2002) 1504-1514
20. Schonwasser D.C., Marais R.M., Marshall C.J., and Parker P.J. Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol. Cell. Biol. 18 (1998) 790-798
21. Sharrocks A.D. Complexities in ETS-domain transcription factor function and regulation: lessons from the TCF (ternary complex factor) subfamily. The Colworth Medal Lecture. Biochem. Soc. Trans. 30 (2002) 1-9
22. Thiel G., and Cilleli G. Regulation of life and death by zinc finger transciption factor Egr-1. J. Cell. Physiol. 193 (2002) 287-292
23. Baron V., Adamson E.D., Calogero A., Ragona G., and Mercola D. The transcription factor Egr-1 is a direct regulator of multiple tumor suppressors including TGFβ1, PTEN, p53, and fibronectin. Cancer Gene Therapy 13 (2006) 115-124
24. Moon Y., Bottone Jr. F.G., McEntee M.F., and Eling T.E. Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1. Mol. Cancer. Ther. 4 (2005) 1551-1558
25. Aicher W.K., Alexander D., Haas C., Kuchen S., Pagenstecher A., Gay S., Peter H.H., and Eibel H. Transcription factor early growth response 1 activity up-regulates expression of tissue inhibitor of metalloproteinases 1 in human synovial fibroblasts. Arthritis Rheum. 48 (2003) 348-359
26. Bein K., and Simons M. Thrombospondin Type 1 Repeats Interact with Matrix Metalloproteinase 2. Regulation of metalloproteinase activity. J. Biol. Chem. 275 (2000) 32167-32173
27. Ogata Y., Enghild J.J., and Nagase H. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J. Biol. Chem. 267 (1992) 3581-3584
28. Ugwu F., Van Hoef B., Bini A., Collen D., and Lijnen H.R. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3). Biochemistry 37 (1998) 7231-7236